Note: Ingredients listed on restricted chemical lists
EC/CAS
63-42-3
Name of the chemical
Lactose C12H22O11
Concentration
N/A
EC/CAS
9005-25-8
Name of the chemical
Starch
Concentration
N/A
EC/CAS
7631-86-9
Name of the chemical
Silver adsorbed on silicon dioxide
Concentration
N/A
General Information
Revision date
2019-01-22
Product name
Hydrochlorothiazide Capsules, USP 12.5mg
Chemical name
dioxide
1.2.1 Relevant identified uses
Diuretic 6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-
Manufacturer Name
ScieGen Pharmaceuticals, Inc
Icons in SDS
Company Information
company name
ScieGen Pharmaceuticals, Inc
GHS Information
Signal word
None
Section 2
Physical hazards
Not classified.
Health hazards
Not classified. OSHA hazard(s) Not classified.
Hazard pictograms
None
Signal word
None. This is a pharmaceutical product designed to be prescribed by a licensed health care professional. Should any person while using this
Hazard statements
product observe any adverse health effects, they should seek medical treatment.
Prevention
Observe good industrial hygiene practices.
Response
Wash hands after handling.
Storage
Store at 25ºC (77ºF); excursions permitted to 15 - 30 °C (59 - 86 ºF).
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations. Incineration of waste at an approved USEPA incinerator is recommended. Hazard(s) not otherwise
Classified (HNOC)
None known.
